Showing 7011-7020 of 9112 results for "".
- RxPhoto Releases Updated HIPPA-Compliant Mobile Clinical Photography Apphttps://practicaldermatology.com/news/rxphoto-releases-updated-mobile-hippa-compliant-clinical-photo-app/2458213/RxPhoto has released version 3 of its mobile medical photography solution for medical practices and providers. Medical practices can now remain HIPAA compliant while using their mobile devices to securely capture, manage and share medical photos and videos.
- Topix Pharmaceuticals Rolls Out Replenix RetinolForte Treatment Serumhttps://practicaldermatology.com/news/topix-pharmaceuticals-rolls-out-replenix-retinolforte-treatment-serum/2458242/Topix Pharmaceuticals is adding Replenix® RetinolForte Treatment Serum to their portfolio of offerings. The serum’s patent-pending, time-released Micropolymer delivery system deposits retinol into t
- Olay Rolls Out The Olay Skin Advisor 2.0https://practicaldermatology.com/news/olay-rolls-out-the-olay-skin-advisor-20/2458270/Olay’s new
- Crescita Therapeutics Announces Management and Board Changeshttps://practicaldermatology.com/news/crescita-therapeutics-announces-management-and-board-changes/2458293/Crescita Therapeutics Inc., a commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms, introduced Ms. Muneerah Kanji, MBA, CPA, CA, Crescita's Corporate Controll
- PuraCap: Video Available to Educate Families, Childrenhttps://practicaldermatology.com/news/puracap-video-available-to-educate-families-children/2458297/A new video from P
- Topline Results from Novan's SB204 Phase 3 Pivotal Trials: Inconsistent Across Trialshttps://practicaldermatology.com/news/novan-reports-topline-results-from-sb204-phase-3-pivotal-trials/2458306/Novan, Inc. (NASDAQ:
- Encore Dermatology Inc. Launches TridesilonTM (desonide) Cream, 0.05% for ADhttps://practicaldermatology.com/news/encore-dermatology-inc-launches-tridesilontm-desonide-cream-005-for-ad/2458318/Encore Dermatology Inc. is rolling out TridesilonTM (desonide) Cream, 0.05% in a 60g tube for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Encore Dermatology Inc. licensed Tride
- ISDIN: Broad Spectrum Sun Protection Cream with DNA Repair Beneficial Post AK Treatmenthttps://practicaldermatology.com/news/isdin-broad-spectrum-sun-protection-cream-with-dna-repair-beneficial-post-ak-treatment/2458319/ISDIN has reported promising results of a 9-month, randomized, investigator-blinded parallel-group study in a poster presentation at the Winter Clinical Conference. The study was designed to evaluate clinical effects of a high SPF film-forming emulsion co
- Study: Partner-Assisted Skin Self-Exams for Melanoma Don't Cause Embarrassmenthttps://practicaldermatology.com/news/study-partner-assisted-skin-self-exams-for-melanoma-dont-cause-embarrassment/2458345/Patients with melanoma may benefit from having their partners help to examine their skin for new skin cancers, and this does not cause embarrassment or discomfort for the patient or partner, finds a new study in
- 8th Annual CSF Meeting Kicks Offhttps://practicaldermatology.com/news/8th-annual-csf-meeting-kicks-off/2458356/The Cosmetic Surgery Forum (CSF), now in its eighth year, was founded by NE-based dermatologist Joel Schlessinger, MD. CSF is a three-day multi-specialty educational symposium that covers the latest research, treatment and techniques in dermatology and cosmetic surgery. Unlike other meetings, res